Register
Register
Register

Project cooperationUpdated on 16 January 2026

Seeking In Silico Modelling for Nanofiber-Based Cancer "Ecological Traps"

Strategy & Research Associate at Migration Biotherapeutics

Cambridge, United Kingdom

About

Migration Biotherapeutics is a UK-based start-up developing the ALIGHT device, a first-in-class "ecological trap" for Glioblastoma (GBM). Our technology utilises electrospun PCL nanofibers to physically redirect invasive tumour cells through contact guidance, preventing infiltration into healthy brain tissue.

For the HORIZON-MISS-2026-02-CANCER-01 call, we are seeking university-based research partners with expertise in in-silico computational modelling and Virtual Human Twin (VHT) development. We aim to create predictive digital models of our device’s physical steering mechanisms to accelerate R&D and provide performance data for First-in-Human trials. This collaboration will help validate the device's efficacy in a virtual environment, significantly de-risking the clinical translation process.

Stage

  • Design - setting the project scope
  • Completing the consortia

Topic

  • HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research

Type

  • Consortium/Coordinator seeks Partners
  • Offering Expertise to Consortias

Organisation

Migration Biotherapeutics

Start-up

Cardiff, United Kingdom

Similar opportunities

  • Project cooperation

    Partner Search: 3D Organoid Expertise for High-Fidelity GBM Device Validation

    • Completing the consortia
    • Offering Expertise to Consortias
    • Design - setting the project scope
    • Consortium/Coordinator seeks Partners
    • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers

    Enoch Alex

    Strategy & Research Associate at Migration Biotherapeutics

    Cambridge, United Kingdom

  • Project cooperation

    Facilitating contacts with cancer researchers at Medical University of Vienna

    • Completing the consortia
    • HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
    • HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
    • HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
    • HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
    • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers

    Reinhard Eckert

    Research Service at Medical University of Vienna

    Vienna, Austria

  • Project cooperation

    Seeking Consortium Partners for “Virtual Human Twin (VHT) Models for Cancer Research” – HORIZON‑MISS‑2026‑02‑CANCER‑01

    • Completing the consortia
    • Offering Expertise to Consortias
    • Design - setting the project scope
    • HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
    • HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
    • HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
    • HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
    • HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
    • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
    • HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)

    Dani Ortiz

    representador legal at TORMENTA‑IA3, SL

    Madrid, Spain